|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 28, 2018 ) The global insulin pumps market estimated to grow at a CAGR of 10.5% during the forecast period from 2018 to 2025. The insulin pumps market for insulin pumps was valued at USD 3,822.44 Mn in 2017 and is estimated to reach US$ 8,264.01 Mn by 2025.According to a new market research study titled 'Insulin Pumps Market to 2025 - Global Analysis and Forecasts by Product, Type and Application, the global insulin pumps market was valued at US$ 3,822.44 Mn in 2017 and is estimated to reach US$ 8,264.01 Mn by 2025.
The insulin pumps market is aimed to describe, define and estimate the forecast for market size of the insulin pumps till 2025. The report strategically analyzes macro and micro-markets to entail the major factors impacting the growth of the global insulin pumps market. The insulin pumps market report for insulin pumps is appropriate to cater the needs and demands of various stakeholders that include manufacturers, distributors and suppliers of insulin pumps, public and private hospitals, academic medical centers and teaching hospitals, privately practicing physicians and surgeons, medical institutes, pharmacies, ambulatory surgical centers and other distribution channels.
Get Sample Copy of this Report at http://bit.ly/2DBwf5A
Major Market Players:
1. Insulet Corporation
2. Medtronic
3. Tandem Diabetes Care, Inc
4. Debiotech S.A
5. CELLNOVO
6. SOOIL Developments Co., Ltd
7. MicroPort Scientific Corporation
8. Valeritas Inc.
9. F. Hoffmann-La Roche Ltd.
10. Ypsomed AG
The increasing funding for research activities is also helps to increasing the growth for the global insulin pumps market in the coming years. In North America, diabetes management is gaining significant importance. With increasing funding for research, new product development is increasing are a rapid pace in the US and other countries. For instance, the Consolidated Appropriations Act for Fiscal Year 2016 increased discretionary funding for the National Institute of Diabetes and Digestive and Kidney Diseases to US$1.81 billion, an increase of over US$68 million compared to FY2015.
This funding will help the institute to expand promising research toward improved treatments and cure for diabetes. Furthermore, the legislation also provided increased funding of US$ 170.12 million for the Division of Diabetes Translation at the Centers for Disease Control and Prevention (CDC). This funding will help the division to accomplish its mission to reduce the preventable burden of diabetes.
Inquire about this Report at http://bit.ly/2zBJHTj
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
The Insight Partners
Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
